CO-DIOVAN

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Estonia, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug CO-DIOVAN contains a combination of these active pharmaceutical ingredients (APIs):

1	Valsartan UNII 80M03YXJ7I - VALSARTAN
	Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II.
	Read more about Valsartan
2	Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CO-DIOVAN Film-coated tablet	MPI, EU: SmPC	Pharmaceutical Benefits Scheme (AU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DA03	Valsartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9372G, 9373H, 9374J, 9481B, 9482C
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02428883, 02428966, 04460477, 04460566, 05030684, 05030690, 05030709, 08654698, 09493116, 10525979, 10525985, 10851578, 10851584, 11031587, 11080048, 11080054, 11367933, 11367962, 11367979, 11367985, 13510518, 15996519, 16234094, 16370124, 16370130, 16370147, 17267173
EE	Ravimiamet	1031342, 1086016, 1086027, 1086038, 1086049, 1086050, 1086061, 1086072, 1086083, 1086094, 1086106, 1259827, 1259838, 1259849, 1259850, 1259861, 1259872, 1259883, 1259894, 1259906, 1259917, 1259928, 1259939, 1875225, 1875236, 1875247, 1875258, 1875269
ES	Centro de información online de medicamentos de la AEMPS	034114215, 034114292, 62206, 65794, 66526, 69930, 69942
GB	Medicines & Healthcare Products Regulatory Agency	138546, 142066, 142068, 142070, 161515, 161517, 180545, 76687, 76690, 81502
HK	Department of Health Drug Office	43807, 49183, 59335, 59336, 59337, 59366, 59367
HR	Agencija za lijekove i medicinske proizvode	HR-H-035681755, HR-H-063837675, HR-H-133986302, HR-H-174157013, HR-H-819796318
IE	Health Products Regulatory Authority	17442, 17913, 17985, 17992, 18705, 18708, 18709, 18710, 18727, 18728, 18729, 18735, 18750, 18751, 18752
IL	מִשְׂרַד הַבְּרִיאוּת	4433, 4696, 4697
LT	Valstybinė vaistų kontrolės tarnyba	1004719, 1004941, 1004942
MT	Medicines Authority	MA1249/02001, MA1249/02002, MA1249/02003, MA1249/02004, MA1249/02005, PI1438/03301A, PI1438/03302A, PI1438/03303A, PI908/04902A, PI908/04903A, PI908/04904A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	355M98
NG	Registered Drug Product Database	04-3691, A4-1503, A4-1787, B4-1425, B4-1426
Switch country to Nigeria in order to find specific presentations of CO-DIOVAN
NL	Z-Index G-Standaard, PRK	50156, 71390, 77097, 85944, 85979
NZ	Medicines and Medical Devices Safety Authority	10588, 10589, 12410, 12411, 8715
PL	Rejestru Produktów Leczniczych	100123490
SG	Health Sciences Authority	10538P, 11339P, 12011P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504090406, 8699504090659, 8699504090970, 8699504091236, 8699504091243, 8699504091977, 8699504091984, 8699504091991
ZA	Health Products Regulatory Authority	32/7.1.3/0336, 34/7.1.3/0441, 37/7.1.3/0225, 41/7.1.3/0148